125 related articles for article (PubMed ID: 32281709)
1. Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma.
Huang X; Young KH; Guo W; Wang Y; Wang X; Xi Y; Wang L; Bai O
J Viral Hepat; 2020 Sep; 27(9):948-950. PubMed ID: 32281709
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
[TBL] [Abstract][Full Text] [Related]
3. Silicon Nanowire Field-Effect Transistor as Label-Free Detection of Hepatitis B Virus Proteins with Opposite Net Charges.
Yong SK; Shen SK; Chiang CW; Weng YY; Lu MP; Yang YS
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821658
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
6. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
J Clin Microbiol; 1992 May; 30(5):1111-9. PubMed ID: 1583107
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Cheng CL; Huang SC; Chen JH; Wei CH; Fang WQ; Su TH; Yuan CT; Liu JH; Chuang MK; Tien HF
Oncologist; 2020 Sep; 25(9):793-802. PubMed ID: 32275807
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Yamauchi N; Maruyama D; Choi I; Atsuta Y; Sakai R; Miyashita K; Moriuchi Y; Tsujimura H; Kubota N; Yamamoto G; Igarashi T; Izutsu K; Yoshida S; Kojima K; Uchida T; Inoue Y; Tsukamoto N; Ohtsuka E; Suzuki S; Inaguma Y; Ichikawa S; Gomyo H; Ushijima Y; Nosaka K; Kurata M; Tanaka Y; Ueda R; Mizokami M; Kusumoto S
Cancer Sci; 2021 May; 112(5):1943-1954. PubMed ID: 33576088
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
[TBL] [Abstract][Full Text] [Related]
10. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.
Ren W; Ye X; Su H; Li W; Liu D; Pirmoradian M; Wang X; Zhang B; Zhang Q; Chen L; Nie M; Liu Y; Meng B; Huang H; Jiang W; Zeng Y; Li W; Wu K; Hou Y; Wiman KG; Li Z; Zhang H; Peng R; Zhu S; Pan-Hammarström Q
Blood; 2018 Jun; 131(24):2670-2681. PubMed ID: 29545328
[TBL] [Abstract][Full Text] [Related]
11. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
12. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection.
Sinha M; Sundar K; Premalata CS; Asati V; Murali A; Bajpai AK; Davuluri S; Acharya KK; Lakshmaiah KC; Babu K G; Jacob LA; Nandan D; Velayutham D; Datta S; Jayshree RS
Sci Rep; 2019 Oct; 9(1):14516. PubMed ID: 31601912
[TBL] [Abstract][Full Text] [Related]
13. Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.
Wu HC; Tsai HW; Teng CF; Hsieh WC; Lin YJ; Wang LH; Yuan Q; Su IJ
Hum Pathol; 2014 Jun; 45(6):1294-301. PubMed ID: 24767856
[TBL] [Abstract][Full Text] [Related]
14. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Chen KL; Chen J; Rao HL; Guo Y; Huang HQ; Zhang L; Shao JY; Lin TY; Jiang WQ; Zou DH; Hu LY; Wirian ML; Cai QQ
Chin J Cancer; 2015 May; 34(5):225-34. PubMed ID: 26058465
[TBL] [Abstract][Full Text] [Related]
17. Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B.
Suzuki K; Uchida T; Shikata T; Moriyama M; Arakawa Y; Mizokami M; Mima F
Liver; 1990 Dec; 10(6):355-64. PubMed ID: 2074733
[TBL] [Abstract][Full Text] [Related]
18. Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients.
Ren W; Wang X; Yang M; Wan H; Li X; Ye X; Meng B; Li W; Yu J; Lei M; Xie F; Jiang W; Kimby E; Huang H; Liu D; Li ZM; Wu K; Zhang H; Pan-Hammarström Q
Blood Adv; 2022 May; 6(9):2731-2744. PubMed ID: 35030632
[TBL] [Abstract][Full Text] [Related]
19. Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.
Wang Y; Wang H; Pan S; Hu T; Shen J; Zheng H; Xie S; Xie Y; Lu R; Guo L
J Cancer; 2018; 9(9):1575-1581. PubMed ID: 29760795
[No Abstract] [Full Text] [Related]
20. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.
Lucifora J; Arzberger S; Durantel D; Belloni L; Strubin M; Levrero M; Zoulim F; Hantz O; Protzer U
J Hepatol; 2011 Nov; 55(5):996-1003. PubMed ID: 21376091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
